Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasm Metastasis × Vemurafenib × Clear all

Phase

Status

Completed 5 Terminated 4 Active not recruiting 3 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 4 Multiple Myeloma 3 Hematologic Neoplasms 3 Thyroid Cancer, Papillary 2 Neoplasms by Site 2 Neoplasms by Histologic Type 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Carcinoma, Anaplastic 1 Rare Tumor 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Lymphoproliferative Disorders 1 Leukemia, Hairy Cell 1 Laryngeal Neoplasms 1 Glioma 1 Erdheim-Chester Disease 1 Colorectal Cancer Metastatic 1 Adenocarcinoma, Follicular 1

Interventions

pembrolizumab 46 Specimen Handling 30 Magnetic Resonance Spectroscopy 27 Biopsy 26 Radiosurgery 19 Gemcitabine 14 Nivolumab 13 Cisplatin 13 Paclitaxel 11 Carboplatin 11 Cyclophosphamide 10 Taxes 9 Pemetrexed 9 Leucovorin 9 Irinotecan 9 Fluorouracil 9 Capecitabine 9 Oxaliplatin 8 Drug Therapy 8 Doxorubicin 8 Cetuximab 8 Bevacizumab 8 trastuzumab deruxtecan 7 Radiotherapy 7 olaparib 6 cemiplimab 6 abemaciclib 6 Standard of Care 6 Folfox protocol 6 Docetaxel 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04817956 2024-02-29

IMPRESS-N

Oslo University Hospital

Phase 2 Recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡